Aberrant methylation of p16(INK4a) in anatomic and gender-specific subtypes of sporadic colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 6, 1999, Pages 501-506

  Wiencke, John K ^a   Zheng, Shichun ^a   Lafuente, Amalia ^b   Lafuente, Maria Jose ^c   Grudzen, Corita ^a   Wrensch, Margaret R ^a   Miike, Rei ^a   Ballesta, Antonio ^d   Trias, Manuel ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital St Pablo   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; DNA;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; DNA DETERMINATION; EARLY DIAGNOSIS; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; CANCER STAGING; CLASSIFICATION; COLORECTAL TUMOR; DNA METHYLATION; GENETICS; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; SEX RATIO; SPAIN; STATISTICAL MODEL;

AGED; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, P16; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; SEX DISTRIBUTION; SPAIN;

EID: 0032589127     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. American Cancer Society. Cancer Facts and Figures, 1995. Atlanta, GA: American Cancer Society, 1995.
2. Shottenfeld, D., and Winewar, S. J. Cancers of the large intestine. In: D. Shottenfeld and J. F. Fraumeni (eds.), Cancer Epidemiology and Prevention, pp. 813-840. New York: Oxford University Press, 1996.
3. Haenszel, W. Cancer mortality among the foreign born in the United States. J. Natl. Cancer Inst., 26: 37-132, 1961.
4. McMicheal, A. J., and Giles, G. G. Cancer in migrants to Australia: extending the descriptive epidemiologic data. Cancer Res., 48: 751-756, 1988.
5. Potter, J. D. Epidemiologic, environmental, and lifestyle issues in colorectal cancer. In: G. P. Young, P. Rozen, and B. Levin (eds.), Prevention and Early Detection of Colorectal Cancer, pp. 23-44. London: WB Saunders, 1996.
6. Demers, R. Y., Severson, R. K., Shottenfeld, D., and Lazar, L. Incidence of colorectal adenocarcinoma by anatomic subsite: an epidemiologic study of time trends and racial differences in the Detroit Michigan area. Cancer (Phila.), 79: 441-447, 1997.
7. Chao, A., Gilliland, F., Hunt, W. C., Bulterys, M., Becker, T. M., and Key, C. R. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico, 1969-1994. Cancer Causes Control, 9: 137-144, 1998.
8. Kampman, E., Potter, J. D., Slattery, M. L., Caan, B. J., and Edward, S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter case-control study in the United States. Cancer Causes Control, 8: 146-158, 1997.
9. Grodstein, F., Martinez, M. E., Platz, E. A., Giovannucci, E., Colditz, G. A., Kautzky, M., Fuchs, C., and Stampfer, M. J. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann. Intern. Med., 128: 705-712, 1998.
10. Potter, J. D., Bostick, R. M., Grandits, G. A., Fosdick, L., Elmer, P., Wood, J., Grambsch, P., and Louis, T. A. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol. Biomark. Prev., 5: 770-784, 1996.
11. Chen, M. J., Longnecker, M. P., Morganstern, H., Lee, E. R., Frankl, H. D., and Haile, R. W. Recent use of hormone replacement therapy and the prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev., 7: 227-230, 1998.
12. Butcher, D., Hassanein, K., Dudgeon, M., Rhodes, J., and Holmes, F. F. Female gender is a major determinant of changing subsite distribution of colorectal cancer with age. Cancer (Phila.), 56: 714-716, 1985.
13. Vobecky, J., Leduc, C., and Devroede, G. Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer (Phila.), 54: 3065-3069, 1984.
14. Alley, P. G., and McNee, R. K. Age and sex differences in right colon cancer. Dis. Colon Rectum, 29: 227-229, 1986.
15. Dubrow, R., Bernstein, J., and Holford, T. R. Age-period-cohort modeling of large-bowel-cancer incidence by anatomic sub-site and sex in Connecticut. Int. J. Cancer, 53: 907-913, 1993.
16. Correa, P., and Haenszel, W. The epidemiology of large bowel cancer. Adv. Cancer Res., 26: 2-141, 1978.
17. McMichael, A. J., and Potter, J. D. Do intrinsic sex differences in lower alimentary tract physiology influence the sex-specific risks for bowel cancer and other biliary and intestinal diseases? Am. J. Epidemiol., 118: 620-627, 1983.
18. McMicheal, A. J., and Potter, J. D. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J. Natl. Cancer Inst., 75: 185-191, 1985.
19. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
20. Lasky, T., and Silbergeld, E. P53 mutations associated with breast, colorectal, liver, lung and ovarian cancer. Environ. Health Perspect., 104: 1324-1331, 1996.
21. O'Sullivan, M. J., McCarthy, T. V., and Doyle, C. T. Familial adenomatous polyposis: from bedside to benchside. Am. J. Clin. Pathol., 109: 521-526, 1998.
22. Marra, G., and Boldand, C. R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes and historical perspective. J. Natl. Cancer Inst., 87: 1114-1125, 1995.
23. Olschwang, S., Hamelin, R., Laurent-Puig, P., Thuille, B., De Rycke, Y., Li, Y. J., Muzeau, F., Girodet, J., Salmon, R. J., and Thomas, G. Alternative genetic pathways in colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA, 94: 12122-12127, 1997.
24. Zingg, J. M., and Jones, P. A. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis (Lond.), 18: 869-882, 1997.
25. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
26. Ahuja, N., Mohan, A. L., Li, Q., Stolker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., and Issa, J. P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res., 57: 3370-3374, 1997.
27. 1NK4a. Exp. Cell Res., 237: 7-13, 1997.
28. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CPG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., I: 686-692, 1995.
29. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tomout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
30. Clark, S. J., Harrison, J., Paul, C. L., and Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
31. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
32. Bautista, D., Obrador, A., Moreno, V., Cabeza, E., Canet, R., Benito, E., Bosch, X., and Costa, J. Ki-ras mutation modifies the protective effect of dietary monounsatruated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol. Biomark. Prev., 6: 57-61 1997.
33. Gonzalgo, M. L., Bender, C. M., You, E. H., Glendening, J. M., Flores, J. F., Walker, G. J., Hayward, N. K., Jones, P. A., and Fountain, J. W. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approach for methylation analysis of primary tumors. Cancer Res., 57: 5336-5347, 1997.
34. Bulfill, J. A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med.. 113: 779-788, 1990.
35. Distler, P., and Holt, P. R. Are right and left-sided colon neoplasms distinct tumors? Dig. Dis., 15: 302-311, 1997.
36. Thibodeau, S. N., French, A. J., Cunningham, J. M., Tester, D., Burgart, L. J., Roche, P. C., McDonnell, S. K., Schaid, D. J., Vockley, C. W., Michels, V. V., Farr, G. H., Jr., and O'Connell, M. J. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res., 58: 1713-1718, 1998.
37. Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., and Thibodeau, S. N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res., 58: 3455-3460, 1998.
38. Kane, M. F., Loda, M., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., and Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57: 808-811, 1997.
39. Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A. H., Lutterbaugh, J. D., Periyasamy, S., Li, G. M., Drummond, J., Modrich, P. L., Sedwick, W. D., and Markowitz, S. D. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl. Acad. Sci. USA, 95: 8698-8702, 1998.
40. Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J. P., Markowitz, S., Willson, J. K., Hamilton, S. R., Kinzler, K. W., Kane, M. F., Kolodner, R. D., Vogelstein, B., Kunkel, T. A., and Baylin, S. B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 95: 6870-6875, 1998.
41. Akiyama, Y., Iwanaga, R., Ishikawa, T., Sakamoto, K., Nishi, N., Nihei, Z., Iwama, T., Saitoh, K., and Yuasa, Y. Mutations of the transforming growth factor-β type II receptor gene are strongly related to sporadic proximal colon carcinoma with microsatellite instability. Cancer (Phila.), 78: 2478-2485, 1996.
42. Togo, G., Toda, N., Kanai, F., Kato, N., Shiratori, Y., Kishi, K., Imazeki, F., Makuuchi, M., and Omata, M. A transforming growth factor B type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res., 56: 5620-5623, 1996.
43. Souza, R. F., Appel, R., Yin, J., Wang, S., Smolinski, K. N., Abraham, J. M., Zou, T. T., Shi, Y. Q., Lei, J., Cottrell, J., Cymes, K., Biden, K., Simms, L., Leggett, B., Lynch, P. M., Frazier, M., Powell, S. M., Harpaz, N., Sugimura, H., Young, J., and Meltzer, S. J. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat. Genet., 14: 255-257, 1996.
44. Breivik, J., Loth, R. A., Melin, G. I., Rognum, T. O., Borresen-Dale, A. L., and Gaudernack, G. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int. J. Cancer, 74: 664-669, 1997.
45. andreyev, H. J. N., Norman, A. R., Cunningham, D., Oates, J. R., and Clarkes, P. A. Kirsten ras mutation in patients with colorectal cancer: the multicenter "RASCAL" study. J. Natl. Cancer Inst., 90: 675-684, 1998.
46. Elnatan, J., Goh, H. S., and Smith, D. R. c-Ki-ras activation and the biological behavior of proximal and distal colonic adenocarcinoma. Eur. J. Cancer, 32A: 491-497, 1996.
47. Breivik, J., Meling, G. I., Spurkland, A., Rognum, T. O., and Gaudernack, G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br. J. Cancer, 69: 367-371, 1994.
48. Gryfe, R., Swallow, C., Bapat, B., Redston, M., Gallinger, S., and Couture, J. Molecular biology of colorectal cancer. Curr. Probl. Cancer, 21: 233-300, 1997.
49. Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Jung, W. E., Li, E., Weinberg, R. A., and Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell, 81: 197-205, 1995.
50. Hiltunen, M. O., Alhonen, L., Koistinaho, J., Myohanen, S., Paakkonen, M., Marin, S., Kosma, V. M., and Janne, J. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int. J. Cancer. 70: 644-648, 1997.
51. Slattery, M. L., Potter, J. D., Coates, A., Ma, K. N., Berry, T. D., Duncan, D. M., and Caan, B. J. Plant foods and colon cancer: an assessment of specific foods and their related nutrients. Cancer Causes Control. 8: 575-590, 1997.
52. Slattery, M. L., Schaffer, D., Edwards, S. L., Ma, K. N., and Potter, J. D. Are dietary factors involved in DNA methylation associated with colon cancer? Nutr. Cancer, 28: 52-62, 1997.
53. Gaglia, P., Atkin, W. S., Whitelaw, S., Talbot, I. C, Williams, C. B., Norhover J. M., and Hodgson, S. V. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut, 36: 385-390, 1995.
54. Nelson, R. L., Dollear, T., Freels, S., and Persky, V. The relation of age, race, gender to the subsite location of colorectal carcinoma. Cancer (Phila.), 801: 193-197, 1997.
55. Lopez-Abente, G., Pollan, M., Vergara, A., Moreno, C., Moreo, P., Ardanaz, E., and Aragones, N. Age-period-cohort modeling of colorectal cancer incidence and mortality in Spain. Cancer Epidemiol. Biomark. Prev., 6: 999-1005, 1997.
56. Cooper, G. S., Yuan, Z., Landefeld, C. S., Johanson, J. F., and Rimm, A. A. A national population-based study of incidence of colorectal cancer and age Implications for screening older Americans. Cancer (Phila.), 75: 775-781, 1995.
57. Zingg, J. M., and Jones, P. A. DNA methylation as a target for drug design. Pharm. Res. (NY). 15: 175-187, 1998.